Advertisement

Syndicate

Physician Resources Home arrow Medical News arrow Not understanding medicare part d still an issue
Not understanding medicare part d still an issue
Written by NetDoc.com Medical News Feed   

CHICAGO—There still appears to be some lack of knowledge regarding Medicare’s Part D prescription drug program, although there is evidence that cost-related medication nonadherence may have improved overall, according to two studies in the April 23/30 issue of JAMA.

Discuss this article on the forums. (0 posts)

 

Before implementation of the Medicare Prescription Drug Improvement and Modernization Act, which was passed by Congress in 2003, millions of individuals who were elderly and disabled had insufficient or no insurance coverage for outpatient medications. “In the face of these economic barriers, several large surveys in the United States have shown that older individuals have resorted to behaviors such as skipping doses, reducing doses, and letting prescriptions go unfilled. Such cost-related medication nonadherence (CRN) is associated with increased risk of myocardial infarction, stroke, and preventable hospitalization,” the authors of the first study write. Since January 2006, Medicare beneficiaries have been able to purchase a prescription drug benefit (Part D), subsidized by Medicare and available through private plans. The impact of Medicare Part D on CRN is unknown.

Jeanne M. Madden, Ph.D., of Harvard Medical School and Harvard Pilgrim Health Care, Boston, and colleagues examined the changes in the prevalences of CRN and spending less on basic needs (such as food) to afford medicines, before and after Part D implementation. The study included information from the Medicare Current Beneficiary Survey (MCBS), in which 24,234 nationally representative, community-dwelling Medicare enrollees were questioned in 2004, 2005, and 2006 (response rate, 72.3 percent).

The researchers found that there was a larger absolute decrease in CRN following Medicare Part D implementation (from 14.1 percent in 2005 to 11.5 percent in 2006) than occurred between 2004 and 2005 (15.2 percent to 14.1 percent, respectively). However, no significant changes in CRN were observed among beneficiaries with fair-to-poor health, despite high baseline CRN prevalence for this group (22.2 percent in 2005) and significant decreases among beneficiaries with good-to-excellent health.

“Overall, our findings suggest that that the intensive medicine needs and financial barriers to access among the sickest beneficiaries may not have been fully addressed by Part D,” the authors write.

There were modest and significant decreases in CRN among lower-income beneficiaries, controlling for changes from 2004 to 2005, but not for higher-income beneficiaries. Significant reductions in spending less on basic needs were observed in both groups (fair-to-poor health; good-to-excellent health).

“In conclusion, we found small but significant population-level decreases in CRN and spending less on basic needs to afford medicines, nearly a year after an unprecedented shift in Medicare policy—the implementation of the Part D drug benefit. Those beneficiaries in poor health or with multiple morbidities who had substantially higher baseline CRN did not experience decreases in CRN associated with Part D implementation, although they did report reductions in spending less on basic needs. Further research is needed to determine which specific aspects of Part D did or did not alleviate the persistent burden of medication costs. Part D claims data, linked to detailed Part D plan characteristics, must be made available to study the impact of the new Medicare drug benefit on actual utilization of medications and health outcomes,” the researchers conclude.
(JAMA. 2008;299[16]:1922-1928.

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

LIMITED KNOWLEDGE OF COST-SHARING REQUIREMENTS OF MEDICARE PART D MAY EFFECT DRUG ADHERENCE

Enrollees in the large Medicare Advantage Part D drug plan have a limited knowledge of the plan’s cost-sharing requirements, and more than one-third report cost-coping behaviors such as reducing drug adherence or switching to a cheaper drug, according to a study in the April 23/30 issue of JAMA.

In comparison with commercial insurance, Part D benefits use complex and high levels of cost sharing to help limit drug costs, including a coverage gap that in 2006 started at $2,250 in total drug costs and ended after $3,600 of beneficiary out-of-pocket spending. “In 2006, 85 percent of stand-alone prescription drug plans and 72 percent of Medicare Advantage Prescription Drug plans included a coverage gap, meaning that beneficiaries were responsible for all of their drug costs during the gap. In addition, 91 percent of stand-alone prescription drug plans and 93 percent of Medicare Advantage Prescription Drug plans in 2006 had tiered cost sharing prior to the coverage gap, under which beneficiaries paid more for higher-tier drugs such as brand-name medications. Failure to understand these complex benefit structures may limit beneficiaries’ abilities to anticipate or manage their medication costs,” the authors write.

John Hsu, M.D., M.B.A., M.S.C.E., of Kaiser Permanente Medical Care Program, Oakland, Calif., and colleagues investigated beneficiaries’ knowledge of their Part D benefit structures, including their awareness of the coverage gap, after their first full year in the program, and cost responses. Telephone interviews were conducted in 2007 in a random sample of community-dwelling Kaiser Permanente-Northern California Medicare Advantage beneficiaries age 65 years or older, with a gap in coverage if they exceeded $2,250 in drug costs (n = 1,040; 74.9 percent response rate). A range of self-reported responses to drug costs was examined, including decreased adherence to prescribed drug use, use of other cost-coping behaviors (such as switching to lower-cost medications), and reports of financial burden (such as going without necessities).

An estimated 40 percent of beneficiaries knew that their drug plan included a coverage gap. Awareness of the gap increased with 2006 drug costs. Approximately 36 percent of beneficiaries reported changing their behavior because of costs; 26 percent reported any cost-coping behavior; 15 percent reported decreasing adherence; and 7 percent reported experiencing financial burdens. The most frequently reported cost-coping behavior was switching to a cheaper drug (15 percent). Among adherence changes, the most frequently reported behavior was not refilling a prescription (8 percent).

In further analyses, beneficiaries with lower household income more frequently reported cost responses. Compared with beneficiaries who were unaware of having a coverage gap, those who were aware more frequently reported any cost response, but had fewer reports of borrowing money or going without necessities.

“...the low levels of knowledge found in this study reinforce the need for both improved education and tools for Part D beneficiaries. Lack of knowledge or [lack of planning] could limit potential intended cost-sharing effects of encouraging more judicious resource use. Lack of awareness also may limit beneficiaries’ ability to avoid higher drug costs. Increased efforts by Medicare and health plans to educate beneficiaries on the details of their Part D cost-sharing structures and levels are needed,” the authors write.
(JAMA. 2008;299[16]:1929-1936.)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Discuss this article on the forums. (0 posts)

 
< Prev   Next >

Common Diseases

Swine Flu - Updates and information on H1N1 2009 (AKA Swine Influenza) pandemic.

Ankylosing spondylitis - Current protocols for diagnosis and treatment options.

Wegener granulomatosis - Autoimmune etiology and clinical course.

Diabetes - disease and management information, including diagnosis, typical treatment plans and diabetes supplies.

Advertisement

Medical Careers

The US medical jobs market has stayed hot for health care providers. Whether you believe that a provider shortage is in the offing or that the ratio of physicians-to-patients is too high, physician jobs and nursing jobs abound.

A wide variety of medical jobs can be found in the netdoc health care job listings. Particular strengths include permanent and locum tenens physician jobs, nursing jobs across the US, and radiology positions.

Other resources include physician salary information, medical career guidance, and the ability to post physician jobs.

Polls

When hiring your medical practice office manager, what was the most important consideration?
 
Copyright 2005 - 2019 Medical Resource Group, LLC. All rights reserved.